Cancerous Tumors

Double whammy for triple negative breast cancer

A promising new combination therapy for a particularly aggressive form of breast cancer has been identified by Weizmann Institute scientists, as was recently reported in Cancer Research. The potential dual-acting therapeutic ...

Dec 05, 2016
popularity0 comments 0

An unexpected role for epigenetic enzymes in cancer

To better understand how cancer initiates and spreads, Yale associate professor of pathology Qin Yan turned to the field of epigenetics, which examines changes in the expression of genes and proteins that do not affect the ...

Dec 06, 2016
popularity1 comments 0

In cancer immunotherapy, one PD-L1 test to rule them all?

Clinical trials have proven the power of immunotherapies targeting PD-L1 or PD-1 in a range of cancers. However, these same trials show that only some patients benefit - tumors must depend on PD-L1 to be affected when medicines ...

Dec 01, 2016
popularity3 comments 0

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Researchers question lifelong immunity to toxoplasmosis

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

Transplanted interneurons can help reduce fear in mice

The expression "once bitten, twice shy" is an illustration of how a bad experience can induce fear and caution. How to effectively reduce the memory of aversive events is a fundamental question in neuroscience. Scientists ...